Orphanin FQ/nociceptin is a physiological regulator of prolactin secretion in female rats

Endocrinology

Volumn 147, Issue 11, 2006, Pages 5087-5093

  Chesterfield, Matthew ^a   Janik, James ^a   Murphree, Emily ^a   Lynn, Courtney ^b   Schmidt, Erin ^a   Callahan, Phyllis ^a  

^a MIAMI UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (CYCLOOCTYLMETHYL) 3 (HYDROXYMETHYL)PEPERIDIN 4 YL 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; ANTISENSE OLIGONUCLEOTIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR ANTAGONIST; OPIATE RECEPTOR; PROLACTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG INHIBITION; DRUG SPECIFICITY; FEMALE; HORMONAL REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; TUBEROHYPOPHYSEAL TRACT;

ANIMALS; ANIMALS, SUCKLING; FEMALE; HYPOTHALAMUS; OPIOID PEPTIDES; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 33751204444     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0707     Document Type: Article

References (59)

1. Freeman ME, Kanyicska B, Lerant AA, Nagy GM 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523-1631
2. Goffin V, Binart N, Touraine P, Kelly PA 2002 Prolactin: the new biology of an old hormone. Ann Rev Physiol 64:47-67
3. Ben-Jonathan N, Hnasko R 2001 Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763
4. Meunier JC, Mollereau C, Tool L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Permenteir M, Constentin K 1995 Isolation and structure of the endogenous agonist of the opioid receptor-like ORL1 receptor. Nature 377:532-535
5. Reinscheid RK, Nothacker HP, Courson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O 1995 Orphanin FQ: a neuropeptide that activates an opioid-like G-protein coupled receptor. Sci 270:792-794
6. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC 1994 ORL1, a novel member of the opioid receptor family. FEBS Lett 341:33-38
7. Bryant W, Janik J, Baumann M, Callahan P 1998 Orphanin FQ stimulates prolactin and growth hormone release in male and female rats. Brain Res 807:228-233
8. 2 does not antagonize orphanin FQ/nociceptin-induced prolactin release. Brain Res Bull 57:695-703
9. 14Tyr]-orphanin FQ binding. J Comp Neurol 412:563-605
10. Neal CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ 1999 Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406:503-547
11. Mollereau C, Mouledous L 2000 Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21:907-917
12. Shieh KR, Pan JT 2001 Effects of orphanin FQ on central dopaminergic neuronal activities and prolactin secretion. Am J Physiol Regul Integr Comp Physiol 280:R705-R712
13. 2 terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem 41:3360-3366
14. Chu SP, Xu NS, Li P, Wang JQ 1999 The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro. Eur J Pharmacol 364:49-53
15. Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D 1998 A new selective antagonist of nociceptin receptor. Br J Pharmacol 123:163-165
16. Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, Calo G 1999 Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension 33:914-919
17. Meis S, Pape HC 1998 Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J Neurosci 18:8133-8144
18. Varani K, Calo G, Rizzi A, Merighi S, Toth G, Guerrini R, Salvadori S, Borea PA, Regoli D 1998 Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. Br J Pharmacol 125:1485-1490
19. 2, a peripheral ORL-1 receptor antagonists, acts as an agonist in the rat spinal cord. Br J Pharmacol 125:949-951
20. 2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray. Br J Pharmacol 128:103-107
21. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur J Pharmacol 357:R1-R3
22. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J Pharmacol Exp Ther 289:173-180
23. 2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol 127:123-130
24. Schlicker E, Wethwein S, Kathmann M, Bauer U 1998 Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedebergs Arch Pharmacol 358:418-422
25. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett 249:127-130
26. Yakimova KS, Pierau RK 1999 Nociceptin orphanin FQ: effects on thermoregulation in rats. Methods Find Exp Clin Pharmacol 21:345-352
27. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharm 126:555-558
28. 2, a purported orphanin FQ antagonist does not block the orphanin FQ induced prolactin secretory response in female rats. Neurosci Lett 345:149-152
29. 4 receptor agonist in the cardiovascular system of anesthetized rats. Peptides 21:1875-1880
30. Berger H, Bigoni R, Albrecht E, Richter RM, Krause M, Bienart M, Calo G 2000 The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties. Peptides 21:1131-1139
31. 2 selectively antagonizes nociceptin/orphanin FQ-stimulated G protein activation in rat brain. J Pharmacol Exp Ther 294:428-433
32. Mollereau C, Simon MJ, Soularue P, Liners F, Vassart G, Meunier JC, Parmetier M 1996 Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 93:8666-8670
33. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ, Watson SJ, Civelli O 1996 Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 93:8677-8682
34. Henderson G, McKnight AT 1997 The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol Sci 18:293-300
35. Reinscheid RK, Nothacker HP, Civelli O 2000 The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice. Peptides 21:901-906
36. Dooley CT, Houghten RA 1996 Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci 59:23-29
37. Kawamoto H, Ozaki S, Itoh Y, Miyaji M, Arai S, Nakashima H, Kato T, Ohta H, Iwasawa Y 1999 Discovery of the first potent and selective small molecule opioid receptor-like (ORL-1) antagonist: (1-[3R,4R)-1-(cyclooctylmethyl)-3- (hydroxymethyl)peperidin-4-yl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one) (J-113397). J Med Chem 42:5061-5063
38. Pellegrino LJ, Pellegrino AS, Cushman AJ 1979 A stereotaxic atlas of the rat brain. 2nd ed. New York: Plenum Press
39. Kehoe L, Parman R, Janik J, Callahan P 1993 Opiate receptor subtype involvement in the stimulation of prolactin release by β-endorphin in female rats. Neuroendocrinol 57:875-883
40. Leventhal L, Mathis JP, Rossi GC, Pasternak GW, Bodnar RJ 1998 Orphan opioid receptor antisense probe blocks orphanin FQ-induced hyperphagia. Eur J Pharmacol 349:R1-R3
41. 1 opiate receptor subtype in the regulation of prolactin and growth hormone secretion by β-endorphin in female rats: studies with naloxonazine. J Neuroendocrinol 4:701-708
42. Callahan P, Janik J, Grandison L, Rabii J 1988 Morphine does not stimulate prolactin release during lactation. Brain Res 442:214-222
43. Jaworski RP, Callahan P, Janik J 1997 Immunoneutralization of β-endorphin blocks prolactin release during suckling without affecting tuberoinfundibular dopaminergic neural activity. Life Sci 61:1301-1311
44. Moore KE, Lookingland KJ 1995 Dopaminergic neuronal systems in the hypothalamus. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fifth generation of progress. New York: Raven Press; 245-256
45. Lookingland KJ, Moore KE 2006 Functional neuroanatomy of hypothalamic dopaminergic neuroendocrine systems. In: Dimmett SB, Bentivoglio M, Bjorklund A, Hokfelt T, eds. Handbook of chemical neuroanatomy. Vol 21. New York: Elsevier; 433-521
46. Palkovits M, Brownstein MJ 1988 Maps and guide to microdissection of the rat brain. New York: Elsevier
47. Callahan P, Klosterman S, Prunty D, Tompkins J, Janik J 2000 Immunoneutralization of endogenous opioid peptides prevents the suckling-induced prolactin increase and the inhibition of tuberoinfundibular dopaminergic neurons. Neuroendocrinology 71:268-276
48. Lowry OH, Rosebrough NJ, Farr AL, Randall R 1951 Protein measurement with the folin phenol reagent. J Biol Chem 193:265-278
49. Trapella C, Guerrini R, Piccagli L, Calo G, Carra G, Spagnolo B, Rubini S, Fanton G, Hebbes C, McDonald J, Lambert DG, Regoli D, Severo S 2006 Identification of an achiral analogue of J-11397 as potent nociceptin/orphanin FQ receptor antagonist. Bioorg Med Chem 14:692-704
50. Koizumi M, Sakoori K, Midorikawa N, Murphy NP 2004 The NOP (ORL1) receptor antagonist compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor mediated mechanism. Br J Pharmcol 143:53-62
51. Kraska A, Bryant W, Murphree E, Callahan P, Janik J 2005 Lack of involvement of dopamine and serotonin during orphanin FQ/nociceptin (OFQ/N)-induced prolactin secretory response. Life Sci 77:1465-1479
52. Netti C, Rapetti D, Sibilia V, Pagani F, Pecile A, Guidobono F 2002 Endocrine effects of centrally injected nociceptin in the rat. Brain Res 938:55-61
53. Netti C, Guidobono F, Sibilia V, Cazzamalli E, Villa I, Pecile A 1989 Effects of brain histamine depletion on stimulated prolactin release in rats. Agents Actions 27:117-119
54. Netti C, Guidobono F, Sibilia V, Pagani F, Villa I, Pecile A 1990 A selective role for brain histamine in prolactin release induced by opiates. Agents Actions 30:223-225
55. Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N, Imura H 1978 Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103:554-558
56. Lan WY, Pu L, Ling K, Shao J, Cheng A, Ma L, Pei G 1997 Molecular characterization and functional expression of opioid receptor-like1 receptor. Cell Res 7:69-77
57. King MA, Rossi GC, Chang AH, Williams L, Pasternak GW 1997 Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Lett 223:113-116
58. Mogil JS, Pasternak GW 2001 The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53:381-415
59. Soaje M, Bregonzio C, Caron RW, Deis RP 2004 Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats. Neuroendocrinology 80:11-20